Delivery Order SPE2DB24D1104-SPE2DB25FYBZ2

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, with a ceiling value of $1,117.48 and a performance period ending on June 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is for the delivery of 4,568,096,981 units of XEOMIN 100 unit vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the medication XEOMIN, with a total ceiling value of $1,117.48. The contract is a Firm Fixed Price arrangement, has no set-aside designation, and is scheduled for completion by June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,822.36 firm fixed-price contract is for the delivery of XEOMIN 100 unit vials. The contract has an ultimate completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 50 unit vials. The contract has a ceiling value of $1,710.00 and is a firm fixed-price delivery order running through April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,174.80, is a delivery order for 4,567,960,815 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XEOMIN 100 unit vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,117.48 and a performance period through July 2, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 200 unit vials, a pharmaceutical product, with a ceiling value of $93,868.32 and a period of performance through July 1, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of XEOMIN 100 unit vials with a ceiling value of $4,469.92 and a performance period ending on June 30, 2025. The contract is a firm fixed-price contract and is not set aside for any special category of vendors. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 100 unit vials, a pharmaceutical product, with a ceiling value of $33,524.40 and a period of performance through June 3, 2025. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYBZ2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the medication XEOMIN, with a ceiling value of $5,587.40 and a period of performance through July 3, 2025. The contract is a firm-fixed-price, non-set-aside award.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/14/25, 12:45 AM